Condition
Contact Dermatitis Irritant
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown2
Terminated1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06189144Not ApplicableUnknown
Testing an Intervention in Irritative Contact Dermatitis
NCT06177314Unknown
Molecular Diagnosis of Allergic Contact Dermatitis
NCT04909983Not ApplicableTerminatedPrimary
An Explorative Study of Treatment of Contact Dermatitis Due to DiabetesDevices
Showing all 3 trials